<?xml version="1.0" encoding="UTF-8"?>

<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">

 

<channel>

<ttl>60</ttl>

<title>Clinical Care Options HIV - Video Podcast</title>

<link>http://clinicaloptions.com/HIV.aspx</link>

<language>en-us</language>

<copyright>&#x2117; &amp; &#xA9; 2006 Clinical Care Options</copyright>

<itunes:subtitle>CCO is your best source for the newest HIV treatment data.</itunes:subtitle>

<itunes:author>Clinical Care Options</itunes:author>

<itunes:summary>Video education programs and animations for HIV treaters</itunes:summary>

<itunes:owner>

<itunes:name>Clinical Care Options HIV</itunes:name>

<itunes:email>vkeane@clinicaloptions.com</itunes:email>

</itunes:owner>

<itunes:image href="http://images.clinicaloptions.com/images/podcast/HIV_podcast_logo_video.jpg" />

<itunes:category text="Science &amp; Medicine">
	<itunes:category text="Medicine" />
	</itunes:category>


<item>
<title>Use of Novel Assays for Detection of Minority HIV Variants</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: From the Lab to the Clinic</itunes:subtitle>
<itunes:summary>Robert Shafer, MD, discusses the use of new research tools to assess minority variants of HIV.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_lab.m4v" length="153766951" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_lab.m4v</guid>
<pubDate>Tue, 26 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>12:36</itunes:duration>
<itunes:keywords>HIV, Clinic, Shafer</itunes:keywords>
</item> 




<item>
<title>Update on Adherence, 2008</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: Clinical Pearl</itunes:subtitle>
<itunes:summary>Lisa Hirschhorn, MD, provides an update on the current understanding of factors that affect adherence as well as interventions to promote adherence in patients with HIV infection.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_pearl.m4v" length="112301896" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_pearl.m4v</guid>
<pubDate>Tue, 26 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>9:22</itunes:duration>
<itunes:keywords>HIV, Stay Tuned, Hirschhorn</itunes:keywords>
</item> 




<item>
<title>Using New Tropism Assays for Antiretroviral Management Decisions</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: Advances in Diagnostics</itunes:subtitle>
<itunes:summary>Paul E. Sax, MD, describes the latest developments in tropism assays.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_advances.m4v" length="102653724" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_advances.m4v</guid>
<pubDate>Mon, 25 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>8:23</itunes:duration>
<itunes:keywords>HIV, Diagnostics, Sax</itunes:keywords>
</item> 



<item>
<title>Kimberly Smith, MD, MPH: When to Start Antiretroviral Therapy</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: Expert View Point</itunes:subtitle>
<itunes:summary>Kimberly Smith, MD, MPH, provides a clinical perspective on when to initiate antiretroviral therapy in treatment-naive patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_expert.m4v" length="69159075" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_expert.m4v</guid>
<pubDate>Fri, 22 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>5:51</itunes:duration>
<itunes:keywords> HIV, Antiretroviral, Smith</itunes:keywords> 
</item>


<item>
<title>CCO Independent Report From the 2008 International Drug Resistance Workshop</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: New This Month</itunes:subtitle>
<itunes:summary>Daniel R. Kuritzkes, MD, reviews some of the most clinically relevant presentations from the 2008 International Drug Resistance Workshop.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_new.m4v" length="146618779" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_audio_StayTuned_v1e3_new.m4v</guid>
<pubDate>Tue, 19 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>11:59</itunes:duration>
<itunes:keywords>HIV,AIDS,Kuritzkes</itunes:keywords>
</item> 




<item>
<title>Management of an Antiretroviral-Experienced Patient With Low-Level Viremia and Availability of Multiple PIs With Suspected Activity</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, moderates a discussion among himself, Edwin DeJesus, MD, FACP, and W. David Hardy, MD, regarding the use of PIs in a treatment-experienced patient</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg5.m4v" length="198223476" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg5.m4v</guid>
<pubDate>Thu, 14 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>16:21</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks, DeJesus, Hardy</itunes:keywords>
</item> 




<item>
<title>Treatment Considerations for a Highly Treatment-Experienced Patient With No Fully Active PIs</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, moderates a discussion among himself, Edwin DeJesus, MD, FACP, and W. David Hardy, MD, regarding the treatment options for a patient with no fully active PIs </itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg6.m4v" length="198312000" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg6.m4v</guid>
<pubDate>Thu, 14 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>16:22</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks, DeJesus, Hardy</itunes:keywords>
</item> 




<item>
<title>Management of an HIV-Infected Female With Dyslipidemia on a PI-Based Regimen</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, moderates a discussion among himself, Edwin DeJesus, MD, FACP, and W. David Hardy, MD, regarding antiretroviral treatment options for a woman with dyslipidemia</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg4.m4v" length="166268614" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg4.m4v</guid>
<pubDate>Wed, 13 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>13:44</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks, DeJesus, Hardy</itunes:keywords>
</item> 




<item>
<title>Selecting an Antiretroviral Regimen for a Woman Recently Diagnosed With HIV</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, moderates a discussion among himself, Edwin DeJesus, MD, FACP, and W. David Hardy, MD, regarding treatment options for an antiretroviral-naive patient</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg2.m4v" length="132776590" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg2.m4v</guid>
<pubDate>Tue, 12 Aug 2008 17:00:00 GMT</pubDate>
<itunes:duration>16:58</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks, DeJesus, Hardy</itunes:keywords>
</item> 




<item>
<title>Making Treatment Decisions for a Chronically Ill Patient With Virologic Failure of an Initial PI-Based Regimen</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, moderates a discussion among himself, Edwin DeJesus, MD, FACP, and W. David Hardy, MD, on how best to manage the treatment of a patient with virologic failure of an initial PI-based regimen</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg3.m4v" length="214544780" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg3.m4v</guid>
<pubDate>Sat, 12 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>17:42</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks, DeJesus, Hardy</itunes:keywords>
</item> 




<item>
<title>Recent Advances in PI Therapy</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>New Insights Into the Use of PIs Across the Treatment Spectrum</itunes:subtitle>
<itunes:summary>Charles B. Hicks, MD, reviews recent data from randomized clinical trials investigating the use of ritonavir-boosted PIs</itunes:summary>
<enclosure url="http://clinicaloptions.com/onc_podcast_video_PIs_seg1.m4v" length="207802190" type="video/mp4" />
<guid>http://clinicaloptions.com/onc_podcast_video_PIs_seg1.m4v</guid>
<pubDate>Wed, 30 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>17:44</itunes:duration>
<itunes:keywords>HIV, AIDS, Hicks</itunes:keywords>
</item> 


<item>
<title>New Data on Abacavir and Implications for Treatment</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: New This Month</itunes:subtitle>
<itunes:summary>Stay Tuned Program Directors Kathleen E. Squires, MD, Kimberly Y. Smith, MD, MPH, and Andrew R. Zolopa, MD, offer perspective on new data on abacavir and their implications for patient management.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_new.m4v" length="116608241" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_new.m4v</guid>
<pubDate>Mon, 07 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>9:35</itunes:duration>
<itunes:keywords>HIV, Squires, Smith, Zolopa</itunes:keywords>
</item> 



 <item>
 <title>Interpreting Antiretroviral Pharmacokinetic Data for Pregnant Patients</title>
 <itunes:author>Clinical Care Options</itunes:author>
 <itunes:subtitle>CCO HIV Stay Tuned: Clinical Pearl</itunes:subtitle>
 <itunes:summary>Sally Hodder, MD, reviews emerging pharmacokinetic data in pregnant patients that may impact development of new regimens for these patients.</itunes:summary>
 <enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_pearl.m4v" length="85197466" type="video/mp4" />
 <guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_pearl.m4v</guid>
 <pubDate>Thu, 03 Jul 2008 17:00:00 GMT</pubDate>
 <itunes:duration>7:18</itunes:duration>
 <itunes:keywords>HIV, pregnant, Hodder</itunes:keywords>
 </item> 


<item>
<title>Use of New Agents in a Patient With Limited Treatment Experience</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: Case of the Month</itunes:subtitle>
<itunes:summary>Paul E. Sax, MD, guides you through the management of a moderately treatment-experienced patient with options limited by coadministered psychiatric medications.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_case.m4v" length="100122006" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_case.m4v</guid>
<pubDate>Tue, 01 Jul 2008 17:00:00 GMT</pubDate>
<itunes:duration>8:12</itunes:duration>
<itunes:keywords>HIV,AIDS,Sax</itunes:keywords>
</item> 



<item>
<title>How Many Agents Does a Treatment-Experienced Patient Need?</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: Expert Viewpoint</itunes:subtitle>
<itunes:summary>W. David Hardy, MD, discusses decision-making strategy for choosing the optimum number of agents for virologic suppression for treatment-experienced patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_expert.m4v" length="87654510" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_expert.m4v</guid>
<pubDate>Mon, 30 Jun 2008 17:00:00 GMT</pubDate>
<itunes:duration>7:12</itunes:duration>
<itunes:keywords>HIV, AIDS, Hardy</itunes:keywords>
</item> 


<item>
<title>HIV Coreceptor Usage and Treatment Progression</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: A Must Read</itunes:subtitle>
<itunes:summary>Barbara Weiser, MD, and Harold Burger, PhD, MD, discuss findings of their recent paper and the implications of X4-specific viral load for patient treatment options.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_read.m4v" length="120723749" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e2_read.m4v</guid>
<pubDate>Thu, 26 Jun 2008 17:00:00 GMT</pubDate>
<itunes:duration>09:54</itunes:duration>
<itunes:keywords>HIV, AIDS, Weiser, Burger</itunes:keywords>
</item> 

 
<item>
<title>Management of a Multidrug-Resistant Patient</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: Case of the Month</itunes:subtitle>
<itunes:summary>Eric Daar, MD, discusses the management of a multidrug-resistant patient.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e1_case.mp4" length="99633561" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e1_case.mp4</guid>
<pubDate>Thu, 29 May 2008 17:00:00 GMT</pubDate>
<itunes:duration>08:15</itunes:duration>
<itunes:keywords>HIV, case, Daar</itunes:keywords>
</item> 
 
 
 
<item>
<title>New Drugs in Clinical Practice: Update From Boston</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>CCO HIV Stay Tuned: New This Month</itunes:subtitle>
<itunes:summary>Sharon L. Walmsley, MSc, MD, FRCPC, reviews data from Boston on new drugs in clinical practice.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e1_new.mp4" length="72389272" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e1_new.mp4</guid>
<pubDate>Tue, 27 May 2008 17:00:00 GMT</pubDate>
<itunes:duration>06:08</itunes:duration>
<itunes:keywords>HIV, retrovirus, Walmsley</itunes:keywords>
</item> 



  <item>
         
         <title>Mechanisms of Insulin Resistance in HIV-Infected Patients</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>A Mechanism of Action Animation from CCO</itunes:subtitle>
         
         <itunes:summary>This 3D animation illustrates the Mechanisms of Insulin Resistance in HIV-Infected Patients. This animation and others are available for use offline from the Clinical Care Options Resource Center for free.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_ani_insulin.mp4" length="13944640" type="video/mp4" />
         
         
         
         <guid>http://clinicaloptions.com/hiv_podcast_video_ani_insulin.mp4</guid>
         
         <pubDate>Tue, 18 Apr 2006 17:00:00 GMT</pubDate>
         
         <itunes:duration>1:53</itunes:duration>
         
         <itunes:keywords>HIV, insulin, retroviruses</itunes:keywords>
        
  </item>

 
 <item>
         
         <title>HIV, Antiretrovirals, and the Blood Brain Barrier</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>A Mechanism of Action Animation from CCO</itunes:subtitle>
         
         <itunes:summary>This 3D animation illustrates the anatomy and functions of the blood-brain barrier, and its role in influencing CNS penetration of HIV and antiretrovirals. This animation and others are available for use offline from the Clinical Care Options Resource Center for free.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_ani_BBB.mp4" length="14238303" type="video/mp4" />
         
         
         
         <guid>http://clinicaloptions.com/hiv_podcast_video_ani_BBB.mp4</guid>
         
         <pubDate>Tue, 18 Apr 2006 17:00:00 GMT</pubDate>
         
         <itunes:duration>1:55</itunes:duration>
         
         <itunes:keywords>HIV, blood brain barrier, retroviruses</itunes:keywords>
        
   </item>

 <item>
         
         <title>Expert Highlight: Late Breaker Sessions - Daniel R. Kuritzkes, MD</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>Video highlights from the 2008 International AIDS Conference</itunes:subtitle>
         
         <itunes:summary>Daniel R. Kuritzkes, MD, highlights clinically relevant data from key studies presented at the 2008 International AIDS Conference Late Breaker Sessions.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Kuritzkes.m4v" length="152440832" type="video/m4v" />
         
         
         
         <guid>http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Kuritzkes.m4v</guid>
         
         <pubDate>Thu, 28 Aug 2008 17:00:00 GMT</pubDate>
         
         <itunes:duration>12:39</itunes:duration>
         
         <itunes:keywords>HIV, Kuritzkes, retroviruses, IAS, AIDS</itunes:keywords>
        
   </item>
 
 <item>
         
         <title>Expert Highlight: Women and HIV - Kathleen E. Squires, MD</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>Video highlights from the 2008 International AIDS Conference</itunes:subtitle>
         
         <itunes:summary>Kathleen E. Squires, MD, recaps studies that will likely impact the management of HIV-infected women while she was on location at the 2008 International AIDS Conference.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Squires.m4v" length="46858240" type="video/m4v" />
         
         
         
         <guid>http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Squires.m4v</guid>
         
         <pubDate>Fri, 12 Sep 2008 17:00:00 GMT</pubDate>
         
         <itunes:duration>3:58</itunes:duration>
         
         <itunes:keywords>HIV, Squires, retroviruses, IAS, AIDS</itunes:keywords>
        
   </item>
 
<item>
         
         <title>Expert Highlight: Poster Recap - Pedro Cahn, MD, PhD</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>Video highlights from the 2008 International AIDS Conference</itunes:subtitle>
         
         <itunes:summary>While on location at the 2008 International AIDS Conference, Pedro Cahn, MD, PhD, commented on the clinical implications of several studies presented at the conference.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Cahn.m4v" length="72892416" type="video/m4v" />
                
         <guid>http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Cahn.m4v</guid>
         
         <pubDate>Wed, 24 Sep 2008 17:00:00 GMT</pubDate>
         
         <itunes:duration>6:03</itunes:duration>
         
         <itunes:keywords>HIV, Cahn, retroviruses, IAS, AIDS</itunes:keywords>
        
   </item>

<item>
         
         <title>Expert Highlight: Newer Antiretrovirals - Kimberly Y. Smith, MD, MPH</title>
         
         <itunes:author>Clinical Care Options</itunes:author>
         
         <itunes:subtitle>Video highlights from the 2008 International AIDS Conference</itunes:subtitle>
         
         <itunes:summary>Kimberly Y. Smith, MD, MPH, discusses the efficacy and safety data from 3 studies presented at the 2008 International AIDS Conference, each investigating newer antiretroviral agents compared with efavirenz in treatment-naive patients.</itunes:summary>
         
         <enclosure url="http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Smith.m4v" length="83451904" type="video/m4v" />
                
         <guid>http://clinicaloptions.com/hiv_podcast_video_MexicoCity2008_Smith.m4v</guid>
         
         <pubDate>Wed, 24 Sep 2008 17:00:00 GMT</pubDate>
         
         <itunes:duration>6:57</itunes:duration>
         
         <itunes:keywords>HIV, Smith, retroviruses, IAS, AIDS</itunes:keywords>
        
   </item>

<item>
<title>Report on Abacavir Safety and Efficacy From IAC 2008</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: New This Month</itunes:subtitle>
<itunes:summary>Andrew R. Zolopa, MD, and Kimberly Y. Smith, MD, MPH, offer their perspectives on the potential clinical implications of the new data on abacavir and cardiovascular risk presented at the 2008 International AIDS Conference in Mexico City.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_new1.m4v" length="188977152" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_new1.m4v</guid>
<pubDate>Wed, 1 Oct 2008 17:00:00 GMT</pubDate>
<itunes:duration>15:27</itunes:duration>
<itunes:keywords>HIV,AIDS,Zolopa,Smith</itunes:keywords>
</item> 

<item>
<title>Update on the Management of Treatment-Experienced Patients From the 2008 International AIDS Conference</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: New This Month</itunes:subtitle>
<itunes:summary>Joseph J. Eron, Jr., MD, summarizes key presentations from the 2008 International AIDS Conference that are likely to impact the management of treatment-experienced patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_new.m4v" length="125902848" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_new.m4v</guid>
<pubDate>Wed, 1 Oct 2008 17:00:00 GMT</pubDate>
<itunes:duration>10:19</itunes:duration>
<itunes:keywords>HIV,AIDS,Eron</itunes:keywords>
</item> 

<item>
<title>A Review of the EACS and BHIVA Antiretroviral Treatment Guidelines</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: Expert Viewpoint</itunes:subtitle>
<itunes:summary>Anton L. Pozniak, MD, FRCP, who is a panel member for the European AIDS Clinical Society and British HIV Association guidelines, provides insight on when to start antiretroviral therapy and explains why differences may exist between guidelines on which agents to use in treatment-naive patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_expert.m4v" length="83943424" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_expert.m4v</guid>
<pubDate>Wed, 1 Oct 2008 17:00:00 GMT</pubDate>
<itunes:duration>6:51</itunes:duration>
<itunes:keywords>HIV,AIDS,Pozniak</itunes:keywords>
</item> 

<item>
<title>Markers of Inflammation in Atherosclerosis for Patients on Antiretroviral Therapy</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: From the Lab to the Clinic</itunes:subtitle>
<itunes:summary>Andrew Carr, MBBS, MD, FRACP, FRCP, discusses recent data regarding markers of inflammation and other processes that are associated with atherosclerosis and cardiovascular disease in HIV-infected patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_lab.m4v" length="130883584" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_lab.m4v</guid>
<pubDate>Wed, 1 Oct 2008 17:00:00 GMT</pubDate>
<itunes:duration>10:42</itunes:duration>
<itunes:keywords>HIV,AIDS,Carr</itunes:keywords>
</item> 

<item>
<title>Initiating Antiretroviral Therapy in TB/HIV-Coinfected Patients</title>
<itunes:author>Clinical Care Options</itunes:author>
<itunes:subtitle>Stay Tuned HIV: Clinical Pearl</itunes:subtitle>
<itunes:summary>Mauro Schechter, MD, PhD, discusses the controversial question of when to start antiretroviral therapy in TB and HIV-coinfected patients.</itunes:summary>
<enclosure url="http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_pearl.m4v" length="83374080" type="video/mp4" />
<guid>http://clinicaloptions.com/hiv_podcast_video_StayTuned_v1e4_pearl.m4v</guid>
<pubDate>Wed, 1 Oct 2008 17:00:00 GMT</pubDate>
<itunes:duration>6:48</itunes:duration>
<itunes:keywords>HIV,AIDS,Schechter</itunes:keywords>
</item> 

<item>
     
     <title>Sharon L. Walmsley, MSc, MD, FRCPC - Expert Highlight: Management of Treatment-Experienced Patients</title>
     
     <itunes:author>Clinical Care Options</itunes:author>
     
     <itunes:subtitle>Video highlights from the 2008 ICAAC/IDSA meeting in Washington D.C.</itunes:subtitle>
     
     <itunes:summary>Sharon L. Walmsley, MSc, MD, FRCPC, reports on several analyses from clinical trials that inform on the assessment of activity of antiretroviral agents in treatment-experienced patients and the optimal construction of regimens for these patients.</itunes:summary>
     
     <enclosure url="http://clinicaloptions.com/hiv_podcast_video_Washington2008_Walmsley.m4v" length="55971840" type="video/mp4" />
     
     
     
     <guid>http://clinicaloptions.com/hiv_podcast_video_Washington2008_Walmsley.m4v</guid>
     
     <pubDate>Wed, 19 Nov 2008 17:00:00 GMT</pubDate>
     
     <itunes:duration>10:45</itunes:duration>
     
     <itunes:keywords>HIV,ICAAC/IDSA,Walmsley</itunes:keywords>
     
 </item>

<item>
     
     <title>Daniel R. Kuritzkes, MD - Expert Highlight: Antiretroviral Resistance and Viral Tropism</title>
     
     <itunes:author>Clinical Care Options</itunes:author>
     
     <itunes:subtitle>Video highlights from the 2008 ICAAC/IDSA meeting in Washington D.C.</itunes:subtitle>
     
     <itunes:summary>Daniel R. Kuritzkes, MD, discusses new data on raltegravir mechanism of action, resistance to integrase inhibitors, viral tropism, and prevalence of the K65R mutation in populations with subtype C virus.</itunes:summary>
     
     <enclosure url="http://clinicaloptions.com/hiv_podcast_video_Washington2008_Kuritzkes.m4v" length="61165568" type="video/mp4" />
     
     
     
     <guid>http://clinicaloptions.com/hiv_podcast_video_Washington2008_Kuritzkes.m4v</guid>
     
     <pubDate>Wed, 19 Nov 2008 17:00:00 GMT</pubDate>
     
     <itunes:duration>15:07</itunes:duration>
     
     <itunes:keywords>HIV,ICAAC/IDSA,Kuritzkes</itunes:keywords>
     
 </item>

<item>
     
     <title>Joseph J. Eron, Jr., MD - Expert Highlight: New Agents</title>
     
     <itunes:author>Clinical Care Options</itunes:author>
     
     <itunes:subtitle>Video highlights from the 2008 ICAAC/IDSA meeting in Washington D.C.</itunes:subtitle>
     
     <itunes:summary>Joseph J. Eron, Jr., MD, describes new data on the investigational maturation inhibitor bevirimat and entry inhibitor PRO 140 and discusses the reanalysis of data from the MERIT trial.</itunes:summary>
     
     <enclosure url="http://clinicaloptions.com/hiv_podcast_video_Washington2008_Eron.m4v" length="81092608" type="video/mp4" />
     
     
     
     <guid>http://clinicaloptions.com/hiv_podcast_video_Washington2008_Eron.m4v</guid>
     
     <pubDate>Wed, 19 Nov 2008 17:00:00 GMT</pubDate>
     
     <itunes:duration>13:39</itunes:duration>
     
     <itunes:keywords>HIV,ICAAC/IDSA,Eron</itunes:keywords>
     
 </item>

<item>
     
     <title>Joel E. Gallant, MD, MPH - Expert Highlight: Timing and Choice of First-Line Antiretroviral Therapy</title>
     
     <itunes:author>Clinical Care Options</itunes:author>
     
     <itunes:subtitle>Video highlights from the 2008 ICAAC/IDSA meeting in Washington D.C.</itunes:subtitle>
     
     <itunes:summary>Joel E. Gallant, MD, MPH, reports on the phase III STARTMRK trial of raltegravir vs efavirenz in antiretroviral-naive patients and on the NA-ACCORD cohort study on when to start antiretroviral therapy.</itunes:summary>
     
     <enclosure url="http://clinicaloptions.com/hiv_podcast_video_Washington2008_Gallant.m4v" length="99934208" type="video/mp4" />
     
     
     
     <guid>http://clinicaloptions.com/hiv_podcast_video_Washington2008_Gallant.m4v</guid>
     
     <pubDate>Wed, 19 Nov 2008 17:00:00 GMT</pubDate>
     
     <itunes:duration>8:20</itunes:duration>
     
     <itunes:keywords>HIV,ICAAC/IDSA,Gallant</itunes:keywords>
     
 </item>

<item>
     
     <title>Kimberly Y. Smith, MD, MPH - Expert Highlight: Switch Studies From Lopinavir/Ritonavir to Raltegravir</title>
     
     <itunes:author>Clinical Care Options</itunes:author>
     
     <itunes:subtitle>Audio highlights from the 2009 Conference on Retroviruses and Opportunistic Infections in Montreal</itunes:subtitle>
     
     <itunes:summary>Kimberly Y. Smith, MD, MPH, describes these interesting results from the SWITCHMRK trial.</itunes:summary>
     
     <enclosure url="http://clinicaloptions.com/hiv_podcast_video_retroviruses2009_Smith.m4v" length="85733376" type="video/mp4" />
     
     
     
     <guid>http://clinicaloptions.com/hiv_podcast_video_retroviruses2009_Smith.m4v</guid>
     
     <pubDate>Thu, 19 Feb 2009 17:00:00 GMT</pubDate>
     
     <itunes:duration>7:06</itunes:duration>
     
     <itunes:keywords>HIV,CROI,Smith</itunes:keywords>
     
 </item>

</channel>

</rss>
